Literature DB >> 9401367

Cystic fibrosis respiratory infections: interactions between bacteria and host defence.

G Döring1.   

Abstract

In cystic fibrosis, impaired mucociliary clearance leads to chronic endobronchial bacterial infection, mostly caused by Pseudomonas aeruginosa. In the early stage of infection, the pathogen produces several extracellular protein toxins which may contribute to its multifactorial virulence before specific antibodies are produced. P. aeruginosa successfully resists phagocytosis by neutrophils, which dominate the local inflammatory response, by switching from a nonmucoid variant to a mucoid phenotype. Chronic infection and inflammation are characterized by neutrophil-released proteinases which may provide favourable growth conditions for the bacterial opportunist. Aerosol therapy with serine proteinase inhibitors is being investigated in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401367

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  10 in total

1.  Elastase deficiency phenotype of Pseudomonas aeruginosa canine otitis externa isolates.

Authors:  S R Petermann; C Doetkott; L Rust
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Involvement of the twin-arginine translocation system in protein secretion via the type II pathway.

Authors:  R Voulhoux; G Ball; B Ize; M L Vasil; A Lazdunski; L F Wu; A Filloux
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 3.  Targeting airway inflammation in cystic fibrosis in children: past, present, and future.

Authors:  Tacjana Pressler
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

4.  Neutrophil cell death, activation and bacterial infection in cystic fibrosis.

Authors:  A P Watt; J Courtney; J Moore; M Ennis; J S Elborn
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

5.  Multiple FadD acyl-CoA synthetases contribute to differential fatty acid degradation and virulence in Pseudomonas aeruginosa.

Authors:  Yun Kang; Jan Zarzycki-Siek; Chad B Walton; Michael H Norris; Tung T Hoang
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

6.  In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients.

Authors:  Mike S Son; Wallace J Matthews; Yun Kang; David T Nguyen; Tung T Hoang
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

7.  The long-chain fatty acid sensor, PsrA, modulates the expression of rpoS and the type III secretion exsCEBA operon in Pseudomonas aeruginosa.

Authors:  Yun Kang; Vladimir V Lunin; Tatiana Skarina; Alexei Savchenko; Michael J Schurr; Tung T Hoang
Journal:  Mol Microbiol       Date:  2009-06-08       Impact factor: 3.501

8.  Two Regulators, PA3898 and PA2100, Modulate the Pseudomonas aeruginosa Multidrug Resistance MexAB-OprM and EmrAB Efflux Pumps and Biofilm Formation.

Authors:  Yun Heacock-Kang; Zhenxin Sun; Jan Zarzycki-Siek; Kanchana Poonsuk; Ian A McMillan; Rungtip Chuanchuen; Tung T Hoang
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  Novel dual regulators of Pseudomonas aeruginosa essential for productive biofilms and virulence.

Authors:  Yun Heacock-Kang; Jan Zarzycki-Siek; Zhenxin Sun; Kanchana Poonsuk; Andrew P Bluhm; Darlene Cabanas; Dawson Fogen; Ian A McMillan; Rungtip Chuanchuen; Tung T Hoang
Journal:  Mol Microbiol       Date:  2018-07-31       Impact factor: 3.501

10.  Spatial transcriptomes within the Pseudomonas aeruginosa biofilm architecture.

Authors:  Yun Heacock-Kang; Zhenxin Sun; Jan Zarzycki-Siek; Ian A McMillan; Michael H Norris; Andrew P Bluhm; Darlene Cabanas; Dawson Fogen; Hung Vo; Stuart P Donachie; Bradley R Borlee; Christopher D Sibley; Shawn Lewenza; Michael J Schurr; Herbert P Schweizer; Tung T Hoang
Journal:  Mol Microbiol       Date:  2017-11-17       Impact factor: 3.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.